We're supporting people to maintain their wellbeing and manage isolation.
Complex Regional Pain Syndrome (CRPS) is a serious health condition, affecting approximately 20,000 people in Australia. It is characterised by severe burning, stinging and stabbing pain. People with CRPS are unable to use their painful limb and their ability to work or participate in normal social activities is severely restricted. Currently, there are no effective treatments for CRPS.
A vast body of research has demonstrated changes in brain processes in CRPS. The MEMOIR trial will investigate the effectiveness of two novel brain-directed treatments to reduce pain and improve function in people with CRPS.
MEMOIR consolidates the expertise of scientists and clinicians from NeuRA (A/Prof James McAuley, A/Prof Sylvia Gustin, Mr Michael Ferraro), the University of South Australia (Prof Lorimer Moseley), the University of Sydney (Prof Andrew McLachlan), the University of Notre Dame Australia Fremantle (Prof Benedict Wand, Prof Eric Visser), the University of Exeter (Prof Sallie Lamb), Brunel University London (Dr Neil O’Connell) and the University of Oxford (Dr Hopin Lee).
Due to the COVID-19 global pandemic, the commencement of MEMOIR has been delayed. Recruitment for MEMOIR will commence in September 2020.
The SafeTrip study aims to investigate how older adults learn protective stepping skills to avoid falls when encountering obstacles, trips and slips. With NeuRA’s cutting-edge motion capture system and other wearable devices, the SafeTrip team will be able to observe and analyse movement and muscle activity during reactive or proactive step training.
The SafeTrip team are looking for older adults aged 65 years and over who:
Eligible candidates will be invited to NeuRA for baseline assessment before being randomly allocated to either the reactive or proactive step training programs. All participants will undertake at least 3 training sessions, however, depending on their allocation, may be invited to undertake 1-3 additional training sessions throughout the year.
For more information or to get involved, please contact the SafeTrip team on 02 9399 1067 or firstname.lastname@example.org. HC190952
Dr Gatt is co-leading a project with speech pathologist Verity MacMillan that focuses on stuttering and its impact on wellbeing in children and their caregivers. The mental health and wellbeing of children who stutter and their caregivers will be evaluated pre-treatment, mid-treatment and post-treatment to evaluate changes in response to stuttering treatment. We will determine the impact that stuttering has on mental wellbeing from the outset, as well as the factors that determine an optimal and faster treatment response.
The investigators on this project include Verity MacMillan (SWSLHD) and Justine Gatt as Co-Leads (NeuRA and UNSW, Australia), and Stacey Sheedy (SWSLHD), Wendy Lloyd (SWSLHD) and Haeme Park (NeuRA and UNSW, Australia) as co-investigators.
This project is currently supported by a SWSLHD Clinical Knowledge Exchange Seed Funding Initiative.